{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T14:32:46Z","timestamp":1793111566467,"version":"4.5.0"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T00:00:00Z","timestamp":1787875200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003745","name":"Wilhelm och Martina Lundgrens Stiftelser","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003745","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005701","name":"\u00c5hl\u00e9n-stiftelsen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005701","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004032","name":"Parkinson Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004032","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008444","name":"Parkinsonfonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008444","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["autonomicneuroscience.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autonomic Neuroscience"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.autneu.2026.103472","type":"journal-article","created":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T13:03:42Z","timestamp":1787922222000},"page":"103472","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Dysfunction of in vitro urinary bladder contractility and relaxation in the 6-OHDA rat model of Parkinson's disease"],"prefix":"10.1016","volume":"268","author":[{"given":"Arghavan","family":"Azadi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Hjelm\u00e9r","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Del Pilar","family":"Murillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filip","family":"Bergquist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Winder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Carlsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autneu.2026.103472_bb0005","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.baga.2015.06.001","article-title":"The vulnerable ventral tegmental area in Parkinson\u2019s disease","volume":"5","author":"Alberico","year":"2015","journal-title":"Basal Ganglia"},{"key":"10.1016\/j.autneu.2026.103472_bb0010","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1002\/nau.21108","article-title":"Rodent models for urodynamic investigation","volume":"30","author":"Andersson","year":"2011","journal-title":"Neurourol.Urodyn."},{"key":"10.1016\/j.autneu.2026.103472_bb0015","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1038\/bjp.2008.6","article-title":"Cholinergic nitric oxide release from the urinary bladder mucosa in cyclophosphamide-induced cystitis of the anaesthetized rat","volume":"153","author":"Andersson","year":"2008","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.autneu.2026.103472_bb0020","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1002\/syn.890090303","article-title":"Heterogeneous binding of [3H]4-DAMP to muscarinic cholinergic sites in the rat brain: evidence from membrane binding and autoradiographic studies","volume":"9","author":"Araujo","year":"1991","journal-title":"Synapse"},{"key":"10.1016\/j.autneu.2026.103472_bb0025","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2023.1249560","article-title":"Soluble guanylate cyclase mediates the relaxation of healthy and inflamed bladder smooth muscle by aqueous nitric oxide","volume":"14","author":"Aronsson","year":"2023","journal-title":"Front. Physiol."},{"key":"10.1016\/j.autneu.2026.103472_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2022.175052","article-title":"Treatment with the soluble guanylate cyclase activator BAY 60-2770 normalizes bladder function in an in vivo rat model of chronic prostatitis","volume":"927","author":"Aydogdu","year":"2022","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.autneu.2026.103472_bb0035","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1002\/mds.22643","article-title":"The PRIAMO study: a multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson\u2019s disease","volume":"24","author":"Barone","year":"2009","journal-title":"Mov. Disord."},{"key":"10.1016\/j.autneu.2026.103472_bb0040","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1111\/j.1476-5381.1970.tb10655.x","article-title":"Time course of the effects of 6-hydroxydopamine on catecholamine-containing neurones in rat hypothalamus and striatum","volume":"40","author":"Bell","year":"1970","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.autneu.2026.103472_bb0045","first-page":"433","article-title":"The total fate of a drug: kinetics of distribution, excretion, and formation of 14 metabolites in rats treated with imipramine","volume":"173","author":"Bickel","year":"1968","journal-title":"Arch. Int. Pharmacodyn. Ther."},{"key":"10.1016\/j.autneu.2026.103472_bb0050","first-page":"S281","article-title":"Brain-first versus gut-first Parkinson\u2019s disease: a hypothesis","volume":"9","author":"Borghammer","year":"2019","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.autneu.2026.103472_bb0055","doi-asserted-by":"crossref","first-page":"5849","DOI":"10.1523\/JNEUROSCI.0626-07.2007","article-title":"The functional impact of the intrastriatal dopamine neuron grafts in parkinsonian rats is reduced with advancing disease","volume":"27","author":"Breysse","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.autneu.2026.103472_bb0060","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/S0022-5347(05)00058-3","article-title":"Central acute D2 stimulation worsens bladder function in patients with mild Parkinson\u2019s disease","volume":"175","author":"Brusa","year":"2006","journal-title":"J. Urol."},{"key":"10.1016\/j.autneu.2026.103472_bb0065","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1212\/01.wnl.0000260605.12506.86","article-title":"Acute vs chronic effects of l-dopa on bladder function in patients with mild Parkinson disease","volume":"68","author":"Brusa","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.autneu.2026.103472_bb0070","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s002109900045","article-title":"Activation and desensitization by cyclic antidepressant drugs of alpha2-autoreceptors, alpha2-heteroreceptors and 5-HT1A-autoreceptors regulating monamine synthesis in the rat brain in vivo","volume":"360","author":"Esteban","year":"1999","journal-title":"Naunyn Schmiedeberg's Arch. Pharmacol."},{"key":"10.1016\/j.autneu.2026.103472_bb0075","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1002\/nau.24322","article-title":"Investigating the associations of mucosal P2Y6 receptor expression and urinary ATP and ADP concentrations, with symptoms of overactive bladder","volume":"39","author":"Firouzmand","year":"2020","journal-title":"Neurourol.Urodyn."},{"key":"10.1016\/j.autneu.2026.103472_bb0080","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1002\/ana.410320510","article-title":"Disease-specific patterns of locus coeruleus cell loss","volume":"32","author":"German","year":"1992","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.autneu.2026.103472_bb0085","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/j.1742-7843.2007.00014.x","article-title":"In vitro characterization of parasympathetic and sympathetic responses in cyclophosphamide-induced cystitis in the rat","volume":"100","author":"Giglio","year":"2007","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.autneu.2026.103472_bb0090","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1254\/jphs.92.143","article-title":"Neuronal excitation in the ventral tegmental area modulates the micturition reflex mediated via the dopamine D1 and D2 receptors in rats","volume":"92","author":"Hashimoto","year":"2003","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.autneu.2026.103472_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.parkreldis.2024.106101","article-title":"Brain-first vs. body-first Parkinson\u2019s disease: an update on recent evidence","volume":"122","author":"Horsager","year":"2024","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.autneu.2026.103472_bb0100","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/j.1600-0773.1980.tb01845.x","article-title":"Mechanisms of the responses to non-cholinergic, non-adrenergic nerve stimulation and to ATP in isolated rabbit urinary bladder: evidence for ADP evoked prostaglandin release","volume":"47","author":"Husted","year":"1980","journal-title":"Acta Pharmacol. Toxicol. (Copenh.)"},{"key":"10.1016\/j.autneu.2026.103472_bb0105","doi-asserted-by":"crossref","DOI":"10.1111\/ene.16497","article-title":"Urodynamic study and its correlation with cardiac meta-iodobenzylguanidine (MIBG) in body-first and brain-first subtypes of Parkinson\u2019s disease","volume":"31","author":"Kim","year":"2024","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.autneu.2026.103472_bb0110","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1016\/j.juro.2011.12.062","article-title":"Suppression of bladder overactivity by adenosine A2A receptor antagonist in a rat model of Parkinson disease","volume":"187","author":"Kitta","year":"2012","journal-title":"J. Urol."},{"key":"10.1016\/j.autneu.2026.103472_bb0115","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/j.eururo.2009.11.042","article-title":"In vitro release of adenosine triphosphate from the urothelium of human bladders with detrusor overactivity, both neurogenic and idiopathic","volume":"57","author":"Kumar","year":"2010","journal-title":"Eur. Urol."},{"key":"10.1016\/j.autneu.2026.103472_bb0120","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1002\/nau.24956","article-title":"Continuous administration of mirabegron has advantages in inhibition of central sensitization compared with short-term treatment cessation in a mouse model of overactive bladder","volume":"41","author":"Kwon","year":"2022","journal-title":"Neurourol.Urodyn."},{"key":"10.1016\/j.autneu.2026.103472_bb0125","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1038\/sj.bjp.0702709","article-title":"Pharmacological characterization of beta-adrenoceptors mediating relaxation of the rat urinary bladder in vitro","volume":"127","author":"Longhurst","year":"1999","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.autneu.2026.103472_bb0130","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0014-2999(88)90349-4","article-title":"Methoctramine, a polymethylene tetraamine, differentiates three subtypes of muscarinic receptor in direct binding studies","volume":"145","author":"Michel","year":"1988","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.autneu.2026.103472_bb0135","doi-asserted-by":"crossref","first-page":"301","DOI":"10.3233\/JPD-140509","article-title":"Local change in urinary bladder contractility following CNS dopamine denervation in the 6-OHDA rat model of Parkinson\u2019s disease","volume":"5","author":"Mitra","year":"2015","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.autneu.2026.103472_bb0140","doi-asserted-by":"crossref","first-page":"E409","DOI":"10.1111\/j.1464-410X.2012.11189.x","article-title":"Modulation of bladder afferent signals in normal and spinal cord-injured rats by purinergic P2X3 and P2X2\/3 receptors","volume":"110","author":"Munoz","year":"2012","journal-title":"BJU Int."},{"key":"10.1016\/j.autneu.2026.103472_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2020.e05472","article-title":"Desipramine, commonly used as a noradrenergic neuroprotectant in 6-OHDA-lesions, leads to local functional changes in the urinary bladder and gastrointestinal tract in healthy rats","volume":"6","author":"Murillo","year":"2020","journal-title":"Heliyon"},{"key":"10.1016\/j.autneu.2026.103472_bb0150","doi-asserted-by":"crossref","DOI":"10.1155\/2023\/9090524","article-title":"6-OHDA-induced changes in colonic segment contractility in the rat model of Parkinson\u2019s disease","volume":"2023","author":"Murillo","year":"2023","journal-title":"Gastroenterol. Res. Pract."},{"key":"10.1016\/j.autneu.2026.103472_bb0155","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1038\/sj.bjp.0701562","article-title":"Characterization of beta-adrenoceptors in urinary bladder: comparison between rat and rabbit","volume":"122","author":"Oshita","year":"1997","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.autneu.2026.103472_bb0160","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/327524a0","article-title":"Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor","volume":"327","author":"Palmer","year":"1987","journal-title":"Nature"},{"key":"10.1016\/j.autneu.2026.103472_bb0165","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.parkreldis.2018.07.005","article-title":"Mirabegron in patients with Parkinson disease and overactive bladder symptoms: a retrospective cohort","volume":"57","author":"Peyronnet","year":"2018","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.autneu.2026.103472_bb0170","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1002\/1520-6777(2001)20:1<105::AID-NAU12>3.0.CO;2-9","article-title":"Role of dopamine D1 and D2 receptors in the micturition reflex in conscious rats","volume":"20","author":"Seki","year":"2001","journal-title":"Neurourol.Urodyn."},{"key":"10.1016\/j.autneu.2026.103472_bb0175","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0064696","article-title":"Urinary ATP may be a dynamic biomarker of detrusor overactivity in women with overactive bladder syndrome","volume":"8","author":"Silva-Ramos","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.autneu.2026.103472_bb0180","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1016\/S0022-5347(17)53509-0","article-title":"Atropine resistance of transmurally stimulated isolated human bladder muscle","volume":"128","author":"Sjogren","year":"1982","journal-title":"J. Urol."},{"key":"10.1016\/j.autneu.2026.103472_bb0185","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1002\/nau.20917","article-title":"Development of bladder dysfunction in a rat model of dopaminergic brain lesion","volume":"30","author":"Soler","year":"2011","journal-title":"Neurourol. Urodyn."},{"key":"10.1016\/j.autneu.2026.103472_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.autneu.2020.102689","article-title":"In vivo paracrine effects of ATP-induced urothelial acetylcholine in the rat urinary bladder","volume":"227","author":"Stenqvist","year":"2020","journal-title":"Auton. Neurosci."},{"key":"10.1016\/j.autneu.2026.103472_bb0195","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0014-2999(95)00221-6","article-title":"In vivo and in vitro effects of muscarinic receptor antagonists on contractions and release of [3H]acetylcholine in the rabbit urinary bladder","volume":"281","author":"Tobin","year":"1995","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.autneu.2026.103472_bb0200","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1016\/S0022-5347(01)64196-X","article-title":"Evidence of adenosine 5\u2032-triphosphate release from nerve and P2x-purinoceptor mediated contraction during electrical stimulation of rat urinary bladder smooth muscle","volume":"158","author":"Tong","year":"1997","journal-title":"J. Urol."},{"key":"10.1016\/j.autneu.2026.103472_bb0205","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1540\/jsmr.40.237","article-title":"Muscarinic receptor subtypes of the bladder and gastrointestinal tract","volume":"40","author":"Uchiyama","year":"2004","journal-title":"J. Smooth Muscle Res."},{"key":"10.1016\/j.autneu.2026.103472_bb0210","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1002\/mds.20867","article-title":"Bladder dysfunction in parkinsonism: mechanisms, prevalence, symptoms, and management","volume":"21","author":"Winge","year":"2006","journal-title":"Mov. Disord."},{"key":"10.1016\/j.autneu.2026.103472_bb0215","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1002\/nau.20054","article-title":"Effects of dopaminergic treatment on bladder function in Parkinson\u2019s disease","volume":"23","author":"Winge","year":"2004","journal-title":"Neurourol.Urodyn."},{"key":"10.1016\/j.autneu.2026.103472_bb0220","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1002\/mds.21253","article-title":"Lower urinary tract symptoms and bladder control in advanced Parkinson\u2019s disease: effects of deep brain stimulation in the subthalamic nucleus","volume":"22","author":"Winge","year":"2007","journal-title":"Mov. Disord."},{"key":"10.1016\/j.autneu.2026.103472_bb0225","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1038\/sj.bjp.0705388","article-title":"Dopaminergic mechanisms underlying bladder hyperactivity in rats with a unilateral 6-hydroxydopamine (6-OHDA) lesion of the nigrostriatal pathway","volume":"139","author":"Yoshimura","year":"2003","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.autneu.2026.103472_bb0230","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/nau.22455","article-title":"Central nervous targets for the treatment of bladder dysfunction","volume":"33","author":"Yoshimura","year":"2014","journal-title":"Neurourol. Urodyn."},{"key":"10.1016\/j.autneu.2026.103472_bb0235","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1001\/archneur.60.3.337","article-title":"Neuronal loss is greater in the locus coeruleus than nucleus basalis and substantia nigra in Alzheimer and Parkinson diseases","volume":"60","author":"Zarow","year":"2003","journal-title":"Arch. Neurol."}],"container-title":["Autonomic Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1566070226000949?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1566070226000949?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T13:35:47Z","timestamp":1793108147000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1566070226000949"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":47,"alternative-id":["S1566070226000949"],"URL":"https:\/\/doi.org\/10.1016\/j.autneu.2026.103472","relation":{},"ISSN":["1566-0702"],"issn-type":[{"value":"1566-0702","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dysfunction of in vitro urinary bladder contractility and relaxation in the 6-OHDA rat model of Parkinson's disease","name":"articletitle","label":"Article Title"},{"value":"Autonomic Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autneu.2026.103472","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"103472"}}